Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Hands up my error misunderstanding about share price in March 2001.Not actually sure what it was.
I have gone back and the relevant RNS is dated 4/3/2001.
Quess what the share price was on that day: 36p! So we are back to the share price that obtained two and a half years ago!
Co High bought just under 9m shares for 20p (it’s a bit more complicated than that)
Clearly after the collapse of the agreement with FUM High Co has been selling their holding.
Can any one help with this history.If it has been over the last few months it will explain a lot.Many IP’s will have been selling on the back of this.
Many thanks for the last post,very little to disagree with.
For my own benefit can someone direct me to the RNS(s) that sets out the history of the involvement of High co and the Chinese connection.In particular the purchase and sale of their shares.
Yesterday saw the share price dip to its lowest in a year.As I have commented before this is truly perverse,given the positive inflection points that have been achieved.Can you think of any other company that secures a patent extension to 2040 and it leads to a 10% fall in the share price?
FUM keep telling us that they are a R and D company.What are they now actually doing?What has happened to the pain relief research or the cannabis research?What are they being paid for.
FUM cannot just release RNS’S if there is nothing to say,even though they don’t release them when there is!( the roll out to multi outlets last month)
Tuesday’s RNS is totally tone deaf given the fragility of the share price.
The interim results have been an objective lesson in how not to communicate to the market.A complete word salad with little to inspire confidence in the near future.
I think the only thing that will turn things around is when those who sold in the mid 40’s will buy again and make a good profit when they sell in the low 50’s.Meanwhile us LTH just watch and suffer in frustration.
Having reflected upon recent posts I have changed my mind about what’s going on here.It is truly perverse that following every new positive development the share price goes down.
I now believe that there is a persistent seller who takes advantage of the good news so that they can sell without crashing the share price.
PI’s then panic seeing the share price going down and sell.
As someone has pointed out if a holder has less than 3% of the share capital,they don’t have to report their changing position.It would still take a considerable time to unwind that sort of holding.
If this analysis is nonsense,then it might be that the share price tracks the reviews on the Boots website!
Sorry I am not following the analysis re who is selling. I am sure it is me!
Are you saying Co-High hold over 9m shares that they are trying to sell? I am
not aware that they are on the share registrar:please enlighten us. Given the holding that you suggest would be disclosed on the register and any significant sells would be subject to disclosure.
I think the sells are PI’s who think if they make £200 profit on a 4% rise they are the next Warren Buffet!!
Just seen an advertisement for Cialis on tv.Makes the point it only works if “turned on”
I have commented before that there is a problem with managing expectations with Eroxon. I think many have the impression that it is some sort of aphrodisiac and then give a negative review when they don’t get a hard on.
Moreover it emerged that the longer you used Eroxon the better it worked.
Not only do we need a reset re presentation of our story but also the advertising message.
I should make it clear I am an investor in the true sense of the word having taken part in two placings,so I am beyond patience with the current situation.
Another negative day.But just look at the trades a couple of dozen sells for modest amounts and the share price goes down 3%.
At the moment there is no confidence to buy for fear that the price will fall further.
I commented on this the other day: why was there not a RNS to announce the end of Boots exclusive deal and the rollout of Eroxon through supermarkets and pharmacies.This was clearly a development that impacts upon sales and may well have effected the share price,instead of getting lost in the word salad of the financial statement.
FUM need an effective PR strategy rather than thinking uncle James Barder’s charisma is all that is needed!
MM’s make money by the fees they receive when there is a trade buying or selling.Clearly it’s a good business model to generate trades.Depending on the prevailing sentiment these will be sales or buys.
The latest financial RNS was very badly composed and Barder in his IV later did not make things any better,notwithstanding his obvious enthusiasm.
I think it was a critical error to more or less discount potential USA sales In forecasting future profits.
This created the environment for MM’s to mark down the share price,which has led to the blood bath of the last two weeks.
Panic has generated trades which generates profit for the MM’s.
Eventually this sell off will run out of steam and there will be a slow rise back to the pre RNS price.
FUM have been a story of one failure after another.They seem to have a gift of snatching defeat from the jaws of victory!
But IP’s aren’t selling at 50p plus .Unless you’re selling shares you bought 2 years ago you must be realising a loss.
I am willing to be corrected.Perhaps some of those selling over the last couple of weeks would enlighten us as to their motivation,and whether they are making a profit.
My view is that it has become a traders share albeit that the traders sell at a loss!
I think the fact that FUM do not anticipate making a profit until 2024 has been a fundamental driver in the latest sell off.Although it should be noted that the volume of trades is relatively low.
The cautious attitude of Barder does not help.
The other factor that has had a negative effect on the share price is the opaque nature of the last RNS.Can any one articulate what profit they are making per sale?
The latest selling will burn itself out and as I have stated before the price will then drift higher probably only to go through the same cycle again and again.
Very interesting post Beechurst. I confess that I had not appreciated the fact that the share price is about the same as it was a year ago.
Given all the positive developments this is just not normal trading it’s almost perverse.
I have been in this share for 15 years,so I have witnessed all of the failures. I concluded long ago that Barder was out of his depth.He once phoned me to explain why the condom failure had occurred.If you remember it all resolved around shelf life issues.
Despite Barder’s short comings we now have a fantastic story to tell.The amount of positive publicity the product has generated is amazing.Only at the weekend Amanda Holden referenced Eroxon.
The projections in the half yearlys deliberately excluded forthcoming sales in the USA from the path to profitability.Why?
I understand the need for caution, but surely Barder could spin the story,without misleading the market, in a far more positive way.
A couple of very interesting replies.
If these punters are selling for a 10% profit,we are talking about having bought at 44/45p.
I think one of the factors maybe fingers getting burnt following positive news.There must be a significant number of punters who bought at 67p and are sitting on losses.Or see an opportunity to sell following positive news and realise their loss.
As I have mentioned before most PI’s (I think the figure is 70%)never make a profit on their share dealing because they are victims of the greed/fear phenomenon.
A number of posters have speculated what the share price might be in the future.Can anyone explain why every time,after the last 5 or 6 positive RNS’S the share price is sold down for 4/5 days before it creeps back to 51/52p.
These are significant inflection points that have no effect on advancing the share price.
I note that in the recent question and answer session the FO observed that we have a large retail investor base,and that this has a negative effect on the share price.This is why FUM are so committed to expanding their institutional base.
Clearly Boots had a time limited exclusive deal with FUM.That has expired and Eroxon is now available in many other outlets.This is very good news.My question is why was no RNS issued informing the market about this fundamental change.
One argument might be that clearly it hasn’t proved to be price sensitive given the ongoing stagnation of the share price.
My suspicion is that FUM want to trumpet this development next week.
However it should not be the case that but through the postings on this BB we would be completely ignorant of an important commercial development.
I never thought we would see the share price revisit the 40’s,given all the positive news.The selling has been unremitting ever since the U.S. deal.
I have commented on this before,and I don’t know if it is of any significance,but unlike previous selling patterns often sales are being split into multiple transactions.There are a number this morning.EG there is one transaction with 9 sales at the same time.
The question: is this to falsely give the impression that there are many more people selling than in reality is the case?
LO are not selling: If they were they would have to issue a TR-1 for every 1% that their holdings dropped by.
Something else is going on which I don’t have the expertise to analyse.
There are a lot of PI’s trading this share.As I have commented before the vast majority never make a profit.
We LTD’s have to just watch in frustration,as I have for over 15 years!!
In the last 6 months the following has happened.
Eroxon on sale in Boots
Very healthy sales
FDA approval
Signed a licensing deal with major player in the US
Sunday Times recommended FUM as a buy.
The share price is nearly 2% down on its price back in March.
I just don’t understand it!!
LO have not been selling for a while.They would be obliged to notify the market of any reduction of 1% of their holdings.That was upto yesterday in my opinion.They would wish to sell in a market that can absorb the volume they would want to offload.No one expected FUM to announce a USA deal so soon after FDA approval.This was massive news.It provided the environment in which to sell 1000000’s of shares.
In one sense this is a vote of confidence in FUM,however it surpresses the share price.LO should be issuing a RNS in the near future.They can be a bit tardy about timing!
Why has there not been a Procative interview? given this significant inflection point.Is FUM on holiday?